National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Childhood Craniopharyngioma Treatment (PDQ®)
Patient Version   Health Professional Version   Last Modified: 01/02/2009



Purpose of This PDQ Summary






General Information






Background Information About Childhood Craniopharyngioma






Histopathologic Classification of Childhood Craniopharyngioma






Diagnostic Evaluation of Childhood Craniopharyngioma






Stage Information






Treatment Options for Newly Diagnosed Childhood Craniopharyngioma






Treatment Options for Recurrent Childhood Craniopharyngioma






Late Effects in Patients Treated for Childhood Craniopharyngioma






Changes to the Summary (01/02/2009)






More Information



Page Options
Print This Page
Print Entire Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Late Effects in Patients Treated for Childhood Craniopharyngioma

Because of their intracranial location and the treatment used for these tumors, craniopharyngiomas may cause acute and long-term morbidity.

Immediate outcome following initial treatment is largely determined by preoperative status, age of the patient, size of the tumor, and aggressiveness of surgical resection. Younger children and infants often have the largest tumors, which are the most difficult to remove surgically. Postoperative mortality is in the range of 0% to 2% when radical surgery is undertaken, and it is the result of intraoperative hemorrhage or hypothalamic damage.[1] Postoperative mortality and outcome are also related to experience of the surgeon.

Quality-of-life issues are important in this group of patients, and are difficult to assess due to various treatment modalities. Whereas intelligence quotient is usually maintained, behavioral issues and memory deficits attributed to the frontal lobe and hypothalamus are common, and occur in about 13% to 55% of patients in various series.[2] Other common problems include visual loss, obesity, and the almost universal need for life-long endocrine replacement with multiple pituitary hormones.

(For more information, refer to the PDQ Late Effects of Treatment for Childhood Cancer summary for specific information about the incidence, type, and monitoring of late effects in childhood and adolescent cancer survivors.)

References

  1. Yaşargil MG, Curcic M, Kis M, et al.: Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients. J Neurosurg 73 (1): 3-11, 1990.  [PUBMED Abstract]

  2. Hoffman HJ, De Silva M, Humphreys RP, et al.: Aggressive surgical management of craniopharyngiomas in children. J Neurosurg 76 (1): 47-52, 1992.  [PUBMED Abstract]

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov